Kreuter J, Haenzel I
Infect Immun. 1978 Feb;19(2):667-75. doi: 10.1128/iai.19.2.667-675.1978.
The adjuvant effects of different polyacrylic products and monomers were tested. Influenza vaccine was used as a model antigen. Addition of monomers resulted in a decrease in the antibody response, though adjuvant activity of the monomers should be expected according to some theories on adjuvant action. The particle size of the polymer adjuvants proved to be a very important parameter for adjuvant activity. Particles of 0.1 to 0.2 micron yielded a good adjuvant effect, whereas conglomerates or particles bigger than 0.5 micron yielded only poor or no adjuvant effects. The adjuvant effect of 0.1- to 0.2-micron particles was much more reproducible than rat of Al(OH)3. Attention is drawn to the importance of using physiochemically reproducible materials, such as polymer particles, for experimental work.
对不同聚丙烯酸产品和单体的佐剂效应进行了测试。流感疫苗用作模型抗原。添加单体导致抗体反应降低,尽管根据一些关于佐剂作用的理论,单体应具有佐剂活性。事实证明,聚合物佐剂的粒径是佐剂活性的一个非常重要的参数。0.1至0.2微米的颗粒产生良好的佐剂效果,而大于0.5微米的聚集体或颗粒仅产生较差的佐剂效果或无佐剂效果。0.1至0.2微米颗粒的佐剂效果比氢氧化铝更具可重复性。需注意在实验工作中使用物理化学性质可重复的材料(如聚合物颗粒)的重要性。